3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Brain Neoplasms
4
Pancreatic Neoplasms
3
Glioblastoma
3
Sarcoma
2
Neoplasms
2
Lung Neoplasms
2
Gliosarcoma
2
Glioma
2
Urothelial Carcinoma of the Bladder
1
Thoracic Neoplasms
1
Stage IA-IIA Breast Cancer
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Resected Pancreatic Adenocarcinoma
1
Recurrence
1
Pinealoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Gastrointestinal Neoplasms
1
Eye Neoplasms
1
Esophageal Neoplasms
1
Ependymoma
1
Desmoplastic Small Round Cell Tumor
1
Chordoma
1
Chondrosarcoma
1
Interventions
Pemetrexed
15
Cisplatin
13
pembrolizumab
6
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
cediranib
3
Radiotherapy
3
Gemcitabine
3
Carboplatin
3
amatuximab
2
Radiotherapy, Intensity-Modulated
2
Radiation
2
Everolimus
2
Drug Therapy
2
Cyclophosphamide
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tremelimumab
1
sodium thiosulfate
1
sargramostim
1
nintedanib
1
napabucasin
1
methoxyamine
1
liposomal doxorubicin
1
incomplete Freund's adjuvant
1
fresolimumab
1
durvalumab
1
defactinib
1
cixutumumab
1
bintrafusp alfa protein, human
1
bemcentinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mesothelioma, Malignant
×
Proton Therapy
×
Clear all
No trials found.